326 related articles for article (PubMed ID: 26589967)
21. Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.
Sheetz JB; Mathea S; Karvonen H; Malhotra K; Chatterjee D; Niininen W; Perttilä R; Preuss F; Suresh K; Stayrook SE; Tsutsui Y; Radhakrishnan R; Ungureanu D; Knapp S; Lemmon MA
Mol Cell; 2020 Aug; 79(3):390-405.e7. PubMed ID: 32619402
[TBL] [Abstract][Full Text] [Related]
22. New insights into the evolutionary conservation of the sole PIKK pseudokinase Tra1/TRRAP.
Elías-Villalobos A; Fort P; Helmlinger D
Biochem Soc Trans; 2019 Dec; 47(6):1597-1608. PubMed ID: 31769470
[TBL] [Abstract][Full Text] [Related]
23. Insights into the evolution of divergent nucleotide-binding mechanisms among pseudokinases revealed by crystal structures of human and mouse MLKL.
Murphy JM; Lucet IS; Hildebrand JM; Tanzer MC; Young SN; Sharma P; Lessene G; Alexander WS; Babon JJ; Silke J; Czabotar PE
Biochem J; 2014 Feb; 457(3):369-77. PubMed ID: 24219132
[TBL] [Abstract][Full Text] [Related]
24. Genomics, evolution, and crystal structure of a new family of bacterial spore kinases.
Scheeff ED; Axelrod HL; Miller MD; Chiu HJ; Deacon AM; Wilson IA; Manning G
Proteins; 2010 May; 78(6):1470-82. PubMed ID: 20077512
[TBL] [Abstract][Full Text] [Related]
25. The nucleotide-binding site of human sphingosine kinase 1.
Pitson SM; Moretti PA; Zebol JR; Zareie R; Derian CK; Darrow AL; Qi J; D'Andrea RJ; Bagley CJ; Vadas MA; Wattenberg BW
J Biol Chem; 2002 Dec; 277(51):49545-53. PubMed ID: 12393916
[TBL] [Abstract][Full Text] [Related]
26. Redefining pseudokinases: A look at the untapped enzymatic potential of pseudokinases.
Pon A; Osinski A; Sreelatha A
IUBMB Life; 2023 Apr; 75(4):370-376. PubMed ID: 36602414
[TBL] [Abstract][Full Text] [Related]
27. Type II Binders Targeting the "GLR-Out" Conformation of the Pseudokinase STRADα.
Smith RHB; Khan ZM; Ung PM; Scopton AP; Silber L; Mack SM; Real AM; Schlessinger A; Dar AC
Biochemistry; 2021 Feb; 60(4):289-302. PubMed ID: 33440120
[TBL] [Abstract][Full Text] [Related]
28. Pseudokinases-remnants of evolution or key allosteric regulators?
Zeqiraj E; van Aalten DM
Curr Opin Struct Biol; 2010 Dec; 20(6):772-81. PubMed ID: 21074407
[TBL] [Abstract][Full Text] [Related]
29. Pseudokinase drug intervention: a potentially poisoned chalice.
Claus J; Cameron AJ; Parker PJ
Biochem Soc Trans; 2013 Aug; 41(4):1083-8. PubMed ID: 23863183
[TBL] [Abstract][Full Text] [Related]
30. A historical overview of protein kinases and their targeted small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
[TBL] [Abstract][Full Text] [Related]
31. Going for broke: targeting the human cancer pseudokinome.
Bailey FP; Byrne DP; McSkimming D; Kannan N; Eyers PA
Biochem J; 2015 Jan; 465(2):195-211. PubMed ID: 25559089
[TBL] [Abstract][Full Text] [Related]
32. Pseudokinases: Prospects for expanding the therapeutic targets armamentarium.
Devang N; Pani A; Rajanikant GK
Adv Protein Chem Struct Biol; 2021; 124():121-185. PubMed ID: 33632464
[TBL] [Abstract][Full Text] [Related]
33. Pseudokinases: Flipping the ATP for AMPylation.
Bardwell L
Curr Biol; 2019 Jan; 29(1):R23-R25. PubMed ID: 30620911
[TBL] [Abstract][Full Text] [Related]
34. Computational tools and resources for pseudokinase research.
O'Boyle B; Shrestha S; Kochut K; Eyers PA; Kannan N
Methods Enzymol; 2022; 667():403-426. PubMed ID: 35525549
[TBL] [Abstract][Full Text] [Related]
35. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death.
Hildebrand JM; Tanzer MC; Lucet IS; Young SN; Spall SK; Sharma P; Pierotti C; Garnier JM; Dobson RC; Webb AI; Tripaydonis A; Babon JJ; Mulcair MD; Scanlon MJ; Alexander WS; Wilks AF; Czabotar PE; Lessene G; Murphy JM; Silke J
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15072-7. PubMed ID: 25288762
[TBL] [Abstract][Full Text] [Related]
36. The dual function of KSR1: a pseudokinase and beyond.
Zhang H; Koo CY; Stebbing J; Giamas G
Biochem Soc Trans; 2013 Aug; 41(4):1078-82. PubMed ID: 23863182
[TBL] [Abstract][Full Text] [Related]
37. A pickup in pseudokinase activity.
Dar AC
Biochem Soc Trans; 2013 Aug; 41(4):987-94. PubMed ID: 23863168
[TBL] [Abstract][Full Text] [Related]
38. Role of carboxylate residues adjacent to the conserved core Walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1).
Payen LF; Gao M; Westlake CJ; Cole SP; Deeley RG
J Biol Chem; 2003 Oct; 278(40):38537-47. PubMed ID: 12882957
[TBL] [Abstract][Full Text] [Related]
39. Nuclear receptor-binding protein 1: a novel tumour suppressor and pseudokinase.
Kerr JS; Wilson CH
Biochem Soc Trans; 2013 Aug; 41(4):1055-60. PubMed ID: 23863178
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide Binding, Evolutionary Insights, and Interaction Partners of the Pseudokinase Unc-51-like Kinase 4.
Preuss F; Chatterjee D; Mathea S; Shrestha S; St-Germain J; Saha M; Kannan N; Raught B; Rottapel R; Knapp S
Structure; 2020 Nov; 28(11):1184-1196.e6. PubMed ID: 32814032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
